Omalizumab is associated with improved asthma outcomes in children and adolescents with serum immunoglobulin E above dosing guidelines

Affiliations

• ¹ Division of Allergy & Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
• ² Division of Infectious Disease, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
• ³ Children's Research Institute, Department of Pediatrics, University of North Carolina, Chapel Hill, NC.
• ⁴ School of Nursing, University of North Carolina, Chapel Hill, NC.
• ⁵ Division of Allergy & Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC. Electronic address: allison_burbank@med.unc.edu.